Company Monitoring Page for Lundbeck

latest headlines for company on cafepharma

Lundbeck pens $2B Alder takeover to boost brain disease pipeline
Fierce Biotech
Mon, 09/16/19 - 09:23 am
Tags:
Lundbeck, Alder Biopharmaceuticals, M&A
Lundbeck strikes $250M Abide buyout, bagging Tourette's drug
Fierce Biotech
Mon, 05/6/19 - 10:50 am
Tags:
Lundbeck, Abide Therapeutics, M&A, Tourette's syndrome
Jazz Pharma, Lundbeck and Alexion Pay $122 Million to Settle Kickback Allegations
BioSpace
Thu, 04/4/19 - 11:02 pm
Tags:
Jazz Pharma, Lundbeck, Alexion, kickbacks, charity
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Endpoints
Mon, 03/11/19 - 09:56 am
Tags:
Lundbeck, Lundbeck Foundation, startups, CRISPR, SNIPR Biome
Lundbeck joins with Elsevier to help manage R&D data
Pharmaforum
Thu, 02/28/19 - 09:47 am
Tags:
Lundbeck, R&D, Elsevier, Reaxis
Antipsychotic from Lundbeck, Otsuka flops again in PhIII trials — this time in bipolar patients
Endpoints
Thu, 02/14/19 - 05:45 pm
Tags:
Lundbeck, Otsuka, brexpiprazole, anti-psychotic, schizophrenia, bipolar disorder
FDA Approves First Generic Version of Lundbeck’s Sabril
RAPS.org
Wed, 01/16/19 - 11:54 pm
Tags:
FDA, Teva Pharmaceutical, Lundbeck, seizures, generics, Sabril, Vigabatrin
Lundbeck Partners with AI Driven Numerate to Tackle Central Nervous System Disorders
CP Wire
Mon, 01/7/19 - 10:14 am
Tags:
Lundbeck, Numerate, artificial intelligence, CNS
Mon, 01/7/19 - 10:05 am
Tags:
Lundbeck, Numerate, artificial intelligence
Lundbeck and Otuska’s brexpiprazole hits the mark in PTSD trial
Fierce Biotech
Fri, 11/30/18 - 10:27 am
Tags:
Lundbeck, Otsuka, brexpiprazole-sertraline, PTSD, clinical trials
Lundbeck’s Lu AF35700 misses schizophrenia endpoint
BioCentury
Thu, 10/25/18 - 11:44 pm
Tags:
Lundbeck, Lu AF35700, schizophrenia
Janssen, Lundbeck and Takeda Raise Issues With FDA Draft Guidance on MDD Drugs
RAPS.org
Mon, 08/20/18 - 11:07 pm
Tags:
FDA, JNJ, Janssen, Lundbeck, Takeda, major depressive disorder, drug development
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Fierce Biotech
Mon, 08/20/18 - 10:08 am
Tags:
Kyowa Hakko Kirin, Parkinson's Disease, KW-6356, Lundbeck
Lundbeck Reaches Across Atlantic, Picks Dunsire for CEO Post
Xconomy
Mon, 07/2/18 - 10:23 pm
Tags:
Deborah Dunsire, Lundbeck, Pharma CEOs
Lundbeck Reaches Settlement With US Department of Justice Over Charity Probe
CP Wire
Thu, 06/7/18 - 10:01 am
Tags:
Lundbeck, settlements, legal
Thu, 06/7/18 - 09:56 am
Tags:
Lundbeck, settlements, legal
Lundbeck to pursue M&A again soon
GoinPharma
Sun, 04/29/18 - 12:12 pm
Tags:
Lundbeck, M&A
Lundbeck bulks up neuro pipeline with Prexton buy
Biopharma Dive
Fri, 03/16/18 - 09:14 pm
Tags:
Lundbeck, Prexton Therapeutics, M&A, foliglurax, Parkinson's Disease
Gloomy results from the research for an Alzheimer’s therapy
GoinPharma
Thu, 11/30/17 - 09:54 am
Tags:
Alzheimer's disease, Merck, Eli Lilly, Lundbeck, Biogen, Denali Therapeutics, Yumanity Therapeutics, drug development
Teva lures Lundbeck chief Schultz with $52M package that makes him among pharma's top paid
Fierce Pharma
Tue, 09/12/17 - 04:26 pm
Tags:
Teva Pharmaceutical, executive pay, Pharma CEOs, Lundbeck, Kåre Schultz

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.